Argent Biopharma Limited Change of OTCQB Company Code
May 23 2024 - 3:00AM
RNS Regulatory News
RNS Number : 6271P
Argent Biopharma Limited
23 May 2024
23
May 2024
Argent BioPharma
Ltd.
Change of OTCQB Company
Code
Argent BioPharma Ltd. (Argent BioPharma or the Company) advises that as of 20 May
2024, the Company's new trading code on the OTCQB changed to
RGTLF.
This adjustment aligns with the
Company's recent change in registered name with the Australian
Securities and Investments Commission (ASIC) and trading code on the ASX and
LSE.
-Ends-
Authorised for release by the board of directors, for further
information please contact:
About Argent
BioPharma
Argent BioPharma purpose is to
address unmet medical needs through the pioneering integration of
Nanotechnology and Multidisciplinary research methods. Our approach
heralds a transformative shift in healthcare, combining the power
of multi-targeted drug therapies with precision nanoscale delivery
to enhance treatment efficacy while reducing side effects. Central
to our ethos is making these innovative treatments accessible,
ensuring they reach those underserved by current medical solutions.
As we endeavour to become globally recognized in the life science
industry, we are committed to bridging healthcare gaps, redefining
industry standards, and providing impactful solutions and hope to
communities worldwide.
Follow us through our social media
channels:
LinkedIn: Argent
BioPharma
Twitter: @ArgentBioPharma
Facebook: Argent BioPharma
This information is provided by RNS, the news service of the
London Stock Exchange. RNS is approved by the Financial Conduct
Authority to act as a Primary Information Provider in the United
Kingdom. Terms and conditions relating to the use and distribution
of this information may apply. For further information, please
contact
rns@lseg.com or visit
www.rns.com.
RNS may use your IP address to confirm compliance with the terms
and conditions, to analyse how you engage with the information
contained in this communication, and to share such analysis on an
anonymised basis with others as part of our commercial services.
For further information about how RNS and the London Stock Exchange
use the personal data you provide us, please see our
Privacy
Policy.
END
MSCPPUUWAUPCUQW
Argent Biopharma (LSE:RGT)
Historical Stock Chart
From Oct 2024 to Nov 2024
Argent Biopharma (LSE:RGT)
Historical Stock Chart
From Nov 2023 to Nov 2024
